Xiaohong Li

1.6k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Xiaohong Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaohong Li has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Xiaohong Li's work include Cancer-related molecular mechanisms research (8 papers), Cancer Genomics and Diagnostics (7 papers) and RNA modifications and cancer (7 papers). Xiaohong Li is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Cancer Genomics and Diagnostics (7 papers) and RNA modifications and cancer (7 papers). Xiaohong Li collaborates with scholars based in China, United States and Sweden. Xiaohong Li's co-authors include Thomas G. Paulson, Brian J. Reid, Carissa A. Sanchez, Carlo C. Maley, Patricia C. Galipeau, Patricia L. Blount, Peter S. Rabinovitch, Jennifer C. Finley, Rosa‐Ana Risques and Qisheng Su and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Xiaohong Li

42 papers receiving 1.1k citations

Hit Papers

Genetic clonal diversity predicts progression to esophage... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Li China 15 531 469 316 305 287 42 1.2k
Anne Trinh United States 13 483 0.9× 563 1.2× 882 2.8× 220 0.7× 91 0.3× 27 1.4k
Emanuele Valtorta Italy 16 357 0.7× 531 1.1× 661 2.1× 331 1.1× 67 0.2× 40 1.2k
Henrica M.J. Werner Norway 22 259 0.5× 471 1.0× 330 1.0× 183 0.6× 61 0.2× 58 1.4k
Hyungjin Rhee South Korea 27 335 0.6× 289 0.6× 381 1.2× 321 1.1× 481 1.7× 66 1.8k
David Páez Spain 20 265 0.5× 559 1.2× 828 2.6× 292 1.0× 211 0.7× 75 1.3k
Elizabeth Comen United States 20 871 1.6× 513 1.1× 968 3.1× 286 0.9× 324 1.1× 46 2.1k
Clare Orange United Kingdom 19 321 0.6× 618 1.3× 428 1.4× 209 0.7× 122 0.4× 44 1.2k
Nurten Gündüz United States 12 692 1.3× 216 0.5× 760 2.4× 355 1.2× 312 1.1× 14 1.4k
Daryl Johnson Australia 3 408 0.8× 527 1.1× 331 1.0× 148 0.5× 216 0.8× 4 1.3k
Venetia Sarode United States 24 617 1.2× 411 0.9× 538 1.7× 253 0.8× 310 1.1× 69 1.4k

Countries citing papers authored by Xiaohong Li

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Li more than expected).

Fields of papers citing papers by Xiaohong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Li. The network helps show where Xiaohong Li may publish in the future.

Co-authorship network of co-authors of Xiaohong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Li. A scholar is included among the top collaborators of Xiaohong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Li. Xiaohong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, John B., et al.. (2025). The Role of SWI/SNF Complex in Bladder Cancer. Journal of Cellular and Molecular Medicine. 29(1). e70348–e70348. 2 indexed citations
2.
Li, Xiaohong, et al.. (2024). β-hydroxybutyrate alleviates neurological deficits by restoring glymphatic and inflammation after subarachnoid hemorrhage in mice. Experimental Neurology. 378. 114819–114819. 9 indexed citations
3.
Li, Xiaohong, et al.. (2023). [Effect of 4 kinds of prosthodontic materials on masticatory and gingival function].. PubMed. 32(4). 405–409. 1 indexed citations
5.
An, Xin, et al.. (2023). Histone modification: Biomarkers and potential therapies in colorectal cancer. Annals of Human Genetics. 87(6). 274–284. 16 indexed citations
6.
Li, Xiaohong, Jinghua Sun, Xiaohua Li, et al.. (2022). Peripheral Blood Transcripts Predict Preoperative Obstructive Total Anomalous Pulmonary Venous Connection. Frontiers in Cardiovascular Medicine. 9. 892000–892000. 1 indexed citations
7.
Chen, Jimei, et al.. (2022). Intersection of the Ubiquitin–Proteasome System with Oxidative Stress in Cardiovascular Disease. International Journal of Molecular Sciences. 23(20). 12197–12197. 23 indexed citations
8.
Yang, Zheng, Shengqi Li, Huaying Liu, et al.. (2022). Identification of key genes and pathways associated with diabetes of the exocrine pancreas. Medicine. 101(34). e29781–e29781. 2 indexed citations
9.
Lu, Lijuan, Baogan Peng, Ke Ma, et al.. (2021). Expert consensus of Chinese Association for the Study of Pain on the application of ozone therapy in pain medicine. World Journal of Clinical Cases. 9(9). 2037–2046. 7 indexed citations
10.
Yang, Zheng, Xiaohong Li, Qisheng Su, et al.. (2020). TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma. BioMed Research International. 2020(1). 3962146–3962146. 11 indexed citations
11.
Tang, Yi, Zheng Yang, Yuling Qiu, et al.. (2020). Effect of Different Expression of Immune‐Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis. BioMed Research International. 2020(1). 6942740–6942740. 7 indexed citations
12.
Su, Qisheng, Yan Sun, Zheng Yang, et al.. (2020). Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma. BioMed Research International. 2020(1). 7510120–7510120. 4 indexed citations
13.
Jia, Qingzhu, Shuangxiu Wu, Jian Bai, et al.. (2020). Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer. Advanced Science. 7(9). 1903410–1903410. 36 indexed citations
14.
Su, Qisheng, et al.. (2019). Low serum bilirubin, albumin, and uric acid levels in patients with Crohn's disease. Medicine. 98(19). e15664–e15664. 27 indexed citations
15.
Xu, Bo, et al.. (2017). Diabetes mellitus carries a risk of esophageal cancer. Medicine. 96(35). e7944–e7944. 34 indexed citations
16.
Li, Xiaohong, Wenchao Li, Xiang Shi, et al.. (2017). Is serum bilirubin associated with the severity of Guillain–Barré syndrome?. International Journal of Neuroscience. 128(7). 595–599. 3 indexed citations
17.
Li, Xiaohong, et al.. (2014). Up-regulated expression of Dicer reveals poor prognosis in laryngeal squamous cell carcinoma. Acta Oto-Laryngologica. 134(9). 959–963. 15 indexed citations
18.
Li, Xiaohong, et al.. (2014). Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience. International Urology and Nephrology. 46(7). 1403–1410. 1 indexed citations
19.
Li, Xiaohong, et al.. (2011). Cardiac Morbidity and Mortality in Women with Ductal Carcinoma In Situ of the Breast Treated with Breast Conservation Therapy. The Breast Journal. 17(5). 470–476. 17 indexed citations
20.
Maley, Carlo C., Patricia C. Galipeau, Jennifer C. Finley, et al.. (2006). Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics. 38(4). 468–473. 517 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026